Neuronal apoptosis inhibitory protein (NAIP)-like immunoreactivity in brains of adult patients with Down syndrome

Journal of Neural Transmission, Supplement

Volumn , Issue 57, 1999, Pages 283-291

  Seidl, R ^e   Bajo, M ^a   Bohm K ^e   LaCasse, E C ^b   MacKenzie, A E ^b   Cairns, N ^c   Lubec, G ^d  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF VIENNA   (Austria)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FRONTAL CORTEX; HUMAN; IMMUNOREACTIVITY; MALE; NEUROPATHOLOGY; OCCIPITAL CORTEX; PARIETAL LOBE; PRIORITY JOURNAL; WESTERN BLOTTING; BRAIN; BRAIN CORTEX; COMPARATIVE STUDY; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; REFERENCE VALUE;

BIRC1 PROTEIN, HUMAN; NERVE PROTEIN; NEURONAL APOPTOSIS INHIBITORY PROTEIN;

ADULT; ALZHEIMER DISEASE; BRAIN; CEREBELLUM; CEREBRAL CORTEX; DOWN SYNDROME; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURONAL APOPTOSIS-INHIBITORY PROTEIN; REFERENCE VALUES;

EID: 0033254955     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6380-1_19     Document Type: Article

References (31)

1. Becker LE, Mito T, Takashima S, Onodera K (1991) Growth and development of the brain in Down syndrome. Prog Clin Biol Res 373: 133-152
2. Bredesen DE (1995) Neural apoptosis. Ann Neurol 38: 839-851
3. Busciglio J, Yankner BA (1995) Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378: 776-779
4. Chen QF, Baird SD, Mahadevan M, BesnerJohnston A, Farahani R, Xuan JY, Lefebvre C, Ikeda JE, Korneluk RG, MacKenzie AE (1998) Sequence of a 131-kb region of 5q13.1 containing the spinal muscular atrophy candidate genes SMN and NAIP. Genomics 48: 121-127
5. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW (1997) Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF kappa B control. Proc Natl Acad Sci USA 94: 10057-10062
6. DelaMonte SM, Sohn YK, Wands JR (1997) Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J Neurol Sci 152: 73-83
7. DelaMonte SM, Sohn YK, Ganju N, Wands JR (1998) p53-and CD95-associated apoptosis in neurodegenerative diseases. Lab Invest 78: 401-411
8. Epstein CJ (1995) Down Syndrome (Trisomy 21). In: Scriver SR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 749-794
9. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE (1998) The inhibitors of apoptosis (IAPs) and their emerging role in cancer. ONCOGENE 17: 3247-3259
10. Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M, Le Paslier D, Frezal J, Cohen D, Weissenbach J, Munnich A, Melki J (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80: 155-165
11. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G, Farahani R, McLean M, Ikeda JE, MacKenzie A, Korneluk RG (1996) Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379: 349-353
12. Liston P, Young SS, MacKenzie AE, Korneluk RG (1997) Life and death decisions: the role of the IAPs in the modulating programmed cell death. Apoptosis 2: 423-441
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275
14. MacKenzie AE (1998) Reply to Burghes [letter]. Am J Hum Genet 62: 485-488
15. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardisation of the neuropathological assessment of Alzheimer's Disease. Neurol 4: 479-486
16. Nadel L, Epstein CJ (1992) Down Syndrome and Alzheimer disease. Wiley-Liss, New York (Prog Clin Biol Res 379)
17. Nagy Z, Esiri MM, Smith AD (1997a) Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol Ber1 93: 294-300
18. Nagy Z, Esiri MM (1997b) Apoptosis-related protein expression in the hippocampus in Alzheimer's disease. Neurobiol Aging 18: 565-571
19. Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC (1997) The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. Embo J 16: 6914-6925
20. Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, Farahani R, Baird S, Besner-Johnston A, Lefebvre C, Kang X, Salih M, Aubry H, Tamai K, Guan X, Ioannou P, Crawford TO, de Jong PJ, Surh L, Ikeda J-E, Korneluk RG, MacKenzie AE (1995) The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80: 167-178
21. Sawa A, Oyama F, Cairns NJ, Amano N, Matsushita M (1997) Aberrant expression of bcl-2 gene family in Down's syndrome brains. Mol Brain Res 48: 53-59
22. Schmidt-Sidor B, Wisniewski KE, Shepard TH, Sersen EA (1990) Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 months. Clin Neuropathol 9: 181-190
23. Seidl R, Fang-Kircher S, Bidmon B, Cairns N, Lubec G (1999) Apoptosis-associated proteins p53 and APO-1/Fas (CD95) in brains of adult patients with Down syndrome. Neurosci Lett 260: 9-12
24. Simons M, Beinroth S, Gleichmann M, Liston P, Korneluk, MacKenzie AE, Bahr M, Klockgether T, Robertson GS, Weller M, Schulz JB (1999) Adenovirus-mediated gene transfer of inhibitors of apoptosis proteins delays apoptosis in cerebellar granule neurons. J Neurochem 72: 292-301
25. Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281: 1312-1316
26. Tierney MC, Fisher RH, Lewis AJ, Torzitto ML, Snow WG, Reid DW, Nieuwstraten P, Van Rooijen LAA, Derks HJGM, Van Wijk R, Bischop A (1988) The NINCDA-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease. Neurol 38: 359-364
27. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS (1998) NF-kappa B antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 281: 1680-1683
28. Wisniewski KE, Kida E (1994) Abnormal neurogenesis and synaptogenesis in Down syndrome brain. Dev Brain Dysfunct 7: 289-301
29. Wisneiwski KE, Wisniewski HM, Wen GY (1985) Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down syndrome. Ann Neurol 17: 278-282
30. Xu DG, Korneluk RG, Tamai K, Wigle N, Hakim A, MacKenzie A (1997a) Distribution of neuronal apoptosis inhibitory protein-like immunoreactivity in the rat central nervous system. J Comp Neurol 382: 247-259
31. Xu DG, Crocker SJ, Doucet JP, St. Jean M, Tamai K, Hakim AM (1997b) Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nat Med 3: 997-1004